EHC Encompass Health Corp

Price Chart

Executive Summary

Encompass Health issued $500 million of 5.875% Senior Notes due 2034 in a private offering, using the net proceeds (~$491.2M) together with cash on hand to redeem $400 million of its 4.500% Senior Notes due 2028 and repay $100 million of its revolving credit facility. This refinancing extends debt maturities while modestly increasing the interest rate, but does not change the overall debt level materially. The transaction is a routine liability management move with no operational impact.

Actionable Insight

Key Facts

• Issued $500M aggregate principal amount of 5.875% Senior Notes due 2034 at par.
• Net proceeds of approximately $491.2M after deducting initial purchasers discount and estimated offering expenses.
• Proceeds used to redeem at par $400M of the $800M outstanding 4.500% Senior Notes due 2028.
• Proceeds also used to repay $100M of outstanding borrowings under the revolving credit facility.
• Notes mature June 1, 2034; interest payable semiannually at 5.875% per annum.
• Notes are senior unsecured obligations guaranteed by certain subsidiaries.

Financial Impact

Issued $500M in new debt at 5.875% (up from 4.50% on redeemed notes), extending maturity from 2028 to 2034. Net debt approximately unchanged as $400M note redemption + $100M revolver repayment offsets new issuance.

Risk Factors

• Higher interest expense could pressure earnings slightly.
• Additional debt capacity used; future leverage flexibility reduced.

Market Snapshot

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

US Market Status